DAXX and ovarian cancer: In contrast, DAXX was found to be closely related to cell proliferation, metastasis, and the development of drug resistance in ovarian cancer8, while Liu et al.29 found that DAXX promotes the growth, proliferation, and migration of ovarian cancer ascites cells in vivo by activating ERK signaling pathways.